BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20563741)

  • 1. Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance.
    Lei Y; Geng Z; Guo-Jun W; He W; Jian-Lin Y
    Mol Cell Biochem; 2010 Nov; 344(1-2):23-31. PubMed ID: 20563741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.
    Zhang Y; Chen ZD; Du CJ; Xu G; Luo W
    Pathol Res Pract; 2009; 205(12):823-7. PubMed ID: 19628339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of flotillin-2 is associated with renal cell carcinoma progression.
    Yan Y; Yang FQ; Zhang HM; Che J; Zheng JH
    Tumour Biol; 2014 Oct; 35(10):10479-86. PubMed ID: 25053596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma.
    Miyata Y; Kanda S; Sakai H; Greer PA
    Cancer Sci; 2013 Jun; 104(6):681-6. PubMed ID: 23445469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Survivin Inhibits Renal Cell Carcinoma Progression and Enhances the Activity of Temsirolimus.
    Carew JS; Espitia CM; Zhao W; Mita MM; Mita AC; Nawrocki ST
    Mol Cancer Ther; 2015 Jun; 14(6):1404-13. PubMed ID: 25808836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental study on induction of renal cell carcinoma apoptosis by antisense oligonucleotide targeting survivin.
    Peng J; Ye Z; Zheng T; Ruan L
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(5):467-9, 472. PubMed ID: 15641694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between filamin A and MMP-9 regulate proliferation and invasion in renal cell carcinoma.
    Sun GG; Wei CD; Jing SW; Hu WN
    Asian Pac J Cancer Prev; 2014; 15(8):3789-95. PubMed ID: 24870795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival.
    Zhang Y; Li J; Song Y; Chen F; Pei Y; Yao F
    Mol Med Rep; 2014 Aug; 10(2):860-6. PubMed ID: 24913320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.
    Xue Y; Wu G; Liao Y; Xiao G; Ma X; Zou X; Zhang G; Xiao R; Wang X; Liu Q; Long D; Yang J; Xu H; Liu F; Liu M; Xie K; Huang R
    Br J Cancer; 2014 Apr; 110(9):2250-60. PubMed ID: 24595000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
    Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD
    Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of survivin gene in thyroid carcinoma and its significance].
    Xiang C; Liu WS; Jia SS
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1761-3. PubMed ID: 17919384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of P27kip1 in renal cell carcinoma and its clinical significance].
    Wu P; Zheng SB
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1883-6, 1889. PubMed ID: 20813693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma.
    Kumagai S; Ishibashi K; Kataoka M; Oguro T; Kiko Y; Yanagida T; Aikawa K; Kojima Y
    Cancer Sci; 2016 Nov; 107(11):1632-1641. PubMed ID: 27589337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity.
    Guan HT; Xue XH; Dai ZJ; Wang XJ; Li A; Qin ZY
    World J Gastroenterol; 2006 May; 12(18):2901-7. PubMed ID: 16718816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
    Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma.
    Baytekin F; Tuna B; Mungan U; Aslan G; Yorukoglu K
    Urol Oncol; 2011; 29(5):502-7. PubMed ID: 19945306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.